A new innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation production enterprise has been established in 2020.It is located at No. 9,Weiyi Road,Hangzhouwan Economic Techchnology Development Zone,Shangyu District ,Shaoxing,Zhejiang 31200. It covers an area of nearly 100 Mu and has a plant area of 80,000 m2.
It has eight chemical synthesis workshops, each with an area of 6000m2.. It can hold nearly 400 reactors of various types, with a total reaction volume of up to 2000 m3. A multifunctional API pilot plant ;It also has an 8000m2 four-story oral solid formulation workshop, which can produce oral tablets and capsules annually up to 5 billion pieces (grain); and owns an 9000m2 comprehensive solid warehouse and and a more than 700m2 Class A material warehouse, etc. The allowed reaction types are: substitution, condensation, oxidation, catalytic hydrogenation, chlorination, amination, etc. The reaction types are complete, and there are also qualifications for using highly toxic chemicals (such as sodium cyanide). A multifunctional API pilot workshop. With an R & D building of 850 m2; a quality management building of 1700 m2, QC is equipped with a full range of analytical equipment such as HPLC, GC, IR, UV, etc.
We got EU GMP approval at September 4, 2023, and US FDA approval at December 11, 2024
Mobile version